Leveraging expertise across the life science, tech, and consumer sectors, Jones Day offers bespoke advice on the whole spectrum of corporate transactions, with a specific focus on cross-border deals, including all-cash acquisitions as well as stock-for-stock mergers. The New York duo of Andrew Levine and Randi Lesnick co-head the practice and offer in-depth knowledge in corporate governance matters as well as in recapitalizations, and spin-offs. From Pittsburgh, David Grubman focuses on activist defense matters, while in Cleveland, Benjamin Stulberg concentrates on takeover preparedness and SEC compliance and Peter Izanec has experience in the food and beverage industries. Also in Cleveland, George Hunter is noted for his ability to advise on public mergers.
Legal 500 redaktioneller Kommentar

Auszeichnungen

Mandantenzufriedenheit

Kernmandanten

  • TotalEnergies
  • Evoqua Water Technologies Corp.
  • Astellas Pharma Inc.
  • J.F. Lehman & Company
  • KKR
  • Roper Technologies
  • CoLift Capital LLC
  • Meridian Bioscience, Inc.
  • Asbury Automotive Group, Inc.
  • Hard Rock International

Highlight-Mandate

  • Advised TotalEnergies on its PIPE investment in NextDecade Corporation and investment in the $18.5bn Rio Grande LNG Project.
  • Advised Evoqua Water Technologies Corp. on its $7.5bn stock-for-stock merger with Xylem Inc.
  • Represented Astellas Pharma Inc. in its $5.9 billion all cash acquisition of IVERIC Bio, Inc.

Anwält*innen

Praxisleitung

Andrew Levine; Randi Lesnick

Weitere Kernanwält*innen

David Grubman; Benjamin Stulberg; Jonn Beeson; Peter Izanec; Jeff Schlege; Robert Profusek; George Hunter; William Zawrotny